See ratings and reviews when you sign up for an account.

fMRI for the Study of Response Inhibition, and Face and Linguistic Processing in Autism

This study is currently Recruiting

April 2007 By Mount Sinai School of Medicine

First Recieved on September 13, 2005

Last Updated on November 15, 2007

Sponsor: Mount Sinai School of Medicine
Information provided by: Mount Sinai School of Medicine
Identifier: NCT00211783


This study investigates face processing, response inhibition and phoneme processing in autistic adults by fMRI.

Study Type: Observational
Study Design: Time Perspective: Prospective


Ages Eligible for Study:18 Years
Genders Eligible for Study:Both
Accepts Healthy Volunteers:Accepts Healthy Volunteers

Inclusion Criteria: - Age range of 18-50 years old - Diagnosis: autism spectrum disorder by Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) and Autism Diagnostic Interview - Revised (ADI-R) - Intelligence quotient (IQ) > 80 - Outpatients Exclusion Criteria: - Subjects with epilepsy - Subjects with history of schizophrenia, schizoaffective disorder or other Axis 1 mental disorders, such as bipolar disorder - Subjects reporting history of encephalitis, phenylketonuria, tuberous sclerosis, fragile X syndrome, anoxia during birth, neurofibromatosis, hypomelanosis of Ito, hypothyroidism, Duchenne muscular dystrophy, and maternal rubella - Subjects who have received depot neuroleptic medication, or other psychoactive drugs within the past 5 weeks.


  • Investigator: Evdokia Anagnostou - Principal Investigator - Mount Sinai School of Medicine


  • Mount Sinai School of Medicine

    New York, New York 10029 United States

Disclaimer: The list and ratings above are for informational purposes only, and is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist or other healthcare professional. The goal of the information is to provide you with a comprehensive view of all available treatments, but should not be construed to indicate that use of any one treatment is safe, appropriate, or effective for you. Decisions about use of a new treatment, or about a change in your current treatment plan, should be in consultation with your doctor or other healthcare professional.